TY - JOUR
T1 - Proximal symphalangism, hyperopia, conductive hearing impairment, and the NOG gene
T2 - 2 new mutations
AU - Thomeer, Henricus G.X.M.
AU - Admiraal, Ronald J.C.
AU - Hoefsloot, Lies
AU - Kunst, Henricus P.M.
AU - Cremers, Cor W.R.J.
PY - 2011/6
Y1 - 2011/6
N2 - Objectives: To report on 2 families with proximal symphalangism syndrome and 2 new NOG gene mutations and to report on the outcomes of exploratory tympanotomy. Study Design: Retrospective chart study. Setting: Tertiary referral center. Patients: A total of 6 patients, one of which underwent an exploratory tympanotomy, were examined from 2 families. Intervention: Exploratory tympanotomy in 1 patient. Main Outcome Measures: Medical and otologic histories and postoperative hearing outcomes. Results: In the patient that was operated upon, the preoperative air conduction hearing threshold of 55 dB was reduced to 41 dB with a residual air bone gap of 21 dB. Furthermore, deoxyribonucleic acid analysis revealed 2 different mutations: a heterozygous nonsense mutation in the NOG gene, c.391C>T (p.Gln131X), and a frameshift mutation in the NOG gene (NOG, c.304del (p.Ala102fs)). Conclusion: NOG gene mutations, which lead to aberrant noggin protein function, give rise to a large spectrum of clinical findings and different symphalangism syndromes. These syndromes are all allelic disorders within the Noggin phenotype spectrum. We report on 2 new mutations that are supplementary to those previously described in the literature.
AB - Objectives: To report on 2 families with proximal symphalangism syndrome and 2 new NOG gene mutations and to report on the outcomes of exploratory tympanotomy. Study Design: Retrospective chart study. Setting: Tertiary referral center. Patients: A total of 6 patients, one of which underwent an exploratory tympanotomy, were examined from 2 families. Intervention: Exploratory tympanotomy in 1 patient. Main Outcome Measures: Medical and otologic histories and postoperative hearing outcomes. Results: In the patient that was operated upon, the preoperative air conduction hearing threshold of 55 dB was reduced to 41 dB with a residual air bone gap of 21 dB. Furthermore, deoxyribonucleic acid analysis revealed 2 different mutations: a heterozygous nonsense mutation in the NOG gene, c.391C>T (p.Gln131X), and a frameshift mutation in the NOG gene (NOG, c.304del (p.Ala102fs)). Conclusion: NOG gene mutations, which lead to aberrant noggin protein function, give rise to a large spectrum of clinical findings and different symphalangism syndromes. These syndromes are all allelic disorders within the Noggin phenotype spectrum. We report on 2 new mutations that are supplementary to those previously described in the literature.
KW - Conductive hearing loss
KW - Facioaudiosymphalangism syndrome
KW - Hyperopia
KW - NOG gene
KW - Stapes ankylosis
KW - Symphalangism
KW - Syndactyli
UR - https://www.scopus.com/pages/publications/79958018672
U2 - 10.1097/MAO.0b013e318211fada
DO - 10.1097/MAO.0b013e318211fada
M3 - Article
C2 - 21358557
AN - SCOPUS:79958018672
SN - 1531-7129
VL - 32
SP - 632
EP - 638
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 4
ER -